Deutsche Bank’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
Other funds holding IPSC
PM
Deutsche Bank's IPSC Position: Q3 2026 in Review
Deutsche Bank reduced its Century Therapeutics (IPSC) stake by 13% in Q3 2026, selling an estimated $31K and leaving 105,095 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #3132.
Deutsche Bank first reported a position in IPSC in Q3 2021 and has held it in 17 quarters since. The position peaked at $295K in Q2 2026. 22 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.
- Deutsche Bank held 105,095 shares of Century Therapeutics worth $180K as of Q3 2026.
- Deutsche Bank sold 15,139 Century Therapeutics shares in Q3 2026, an estimated $31K.
- Century Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #3132 holding.
- Deutsche Bank first reported a position in Century Therapeutics in Q3 2021 and has held it in 17 quarters since.
- Deutsche Bank's Century Therapeutics position peaked at $295K in Q2 2026.
- 22 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.
Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.